Latest news with #PaulNewsome
Business Insider
3 days ago
- Business
- Business Insider
Piper Sandler Remains a Buy on Travelers Companies (TRV)
Piper Sandler analyst Paul Newsome reiterated a Buy rating on Travelers Companies (TRV – Research Report) today and set a price target of $310.00. The company's shares opened today at $273.31. Confident Investing Starts Here: According to TipRanks, Newsome is a top 25 analyst with an average return of 16.0% and a 76.86% success rate. Newsome covers the Financial sector, focusing on stocks such as Arthur J Gallagher & Co, Palomar Holdings, and Chubb. In addition to Piper Sandler, Travelers Companies also received a Buy from Evercore ISI's David Motemaden in a report issued on May 28. However, on May 27, Wells Fargo maintained a Hold rating on Travelers Companies (NYSE: TRV). Based on Travelers Companies' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $11.81 billion and a net profit of $395 million. In comparison, last year the company earned a revenue of $11.23 billion and had a net profit of $1.12 billion Based on the recent corporate insider activity of 122 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TRV in relation to earlier this year. Earlier this month, William Heyman, the Vice Chairman of TRV sold 2,000.00 shares for a total of $553,000.00.
Yahoo
07-05-2025
- Business
- Yahoo
Is The Travelers Companies, Inc. (TRV) the Best Dow Stock?
We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where The Travelers Companies, Inc. (NYSE:TRV) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US. It represents the strength of the US economy and carries great historical significance as well. It also acts as a reference point for analysts and investors. However, not all stocks within this elite group of companies perform equally. While some thrive on innovation and economic boom, others struggle due to various setbacks and economic trends. We decided to break down the index and find out the best and worst stocks, looking at what was making them perform unexpectedly this year. Methodology In order to come up with our ranking of the best and worst Dow stocks, we first assigned a rank to each stock based on the number of hedge funds holding the stock. We then looked at the short interest in each stock and assigned the top rank to the company with the least short interest. We then combined the two ranks to see which stock was the best on average. The list is in ascending order, with the best stock taking the number one spot. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). Is The Travelers Companies, Inc. (TRV) the Best Dow Stock? A woman signing a policy document while a representative from the insurance company looks on. The Travelers Companies, Inc. (NYSE:TRV) Number of Hedge Fund Holders: 52 Short Interest as of Apr 30, 2025: 1.42% The Travelers Companies, Inc. (NYSE:TRV) is a personal and commercial property and casualty insurance services and products provider to associations, businesses, individuals, and government units. The company recently received back-to-back upgrades from analysts, making it a great start to the year. The insurance company first earned an upgrade from Piper Sandler right after the solid Q4 earnings. Analysts noted that the stock was inexpensive and upgraded it from Neutral to Overweight with a raised price target of $310. Analysts Paul Newsome and Cam Bianchi favorably viewed its faster-than-expected recovery of personal lines profitability and sustainable margins in commercial lines. Following the same optimistic sentiment, Keefe, Bruyette & Woods also upgraded the insurer from Market Perform to Outperform. The firm pointed out a potential $1.39 billion overestimation of its 2024 loss reserves. Additionally, KBW increased its 2025 reserve release estimates from $315 million to $392 million, which raises its EPS estimates as well.
